Circulating levels of tartrate-resistant acid phosphatase in macrophage-activated lung disease.
Tartrate-resistant acid phosphatase (TrACP) is abundant in alveolar macrophages, suggesting that these cells might contribute to the activity of this isoenzyme in sera of patients with conditions characterized by activation of alveolar macrophages. TrACP was therefore measured in patients with pulmonary sarcoidosis and cryptogenic fibrosing alveolitis and compared with values in controls. Since osteoclasts are known to be the main source of TrACP in serum several indices of bone-turnover were also measured: serum bone-specific alkaline phosphatase and urine hydroxyproline:creatinine ratios. Patients with Paget's disease of bone constituted a reference group presenting increased bone turnover. TrACP was not significantly higher in the lung-disease groups than in controls, although there was a strong positive correlation with angiotensin-converting enzyme in pulmonary sarcoidosis. As expected, TrACP activity was elevated together with the other indices of bone turnover in Paget's disease. It is unlikely that TrACP from alveolar macrophages contributes significantly to serum acid phosphatase activity in lung disease.
Kehely
A
A
Department of Chemical Pathology, Royal Postgraduate Medical School, London, UK.
Moss
D W
DW
D000135:Acid Phosphatase / Q000097:blood*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D008171:Lung Diseases / Q000201:enzymology*; D008262:Macrophage Activation; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000201:enzymology*; D011658:Pulmonary Fibrosis / Q000201:enzymology*; D012507:Sarcoidosis / Q000201:enzymology*; D000071681:Tartrate-Resistant Acid Phosphatase; D013644:Tartrates / Q000494:pharmacology
D007527:Isoenzymes; D013644:Tartrates; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase